These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 10982153

  • 1. Anticonvulsant-induced suppression of IFN-gamma production by lymphocytes obtained from cervical lymph nodes in glioma-bearing mice.
    Yamada M, Ohkawa M, Tamura K, Mabuchi E, Kishima H, Tamura M, Shimizu K.
    J Neurooncol; 2000 Apr; 47(2):125-32. PubMed ID: 10982153
    [Abstract] [Full Text] [Related]

  • 2. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes.
    Rice CD, Baldwin NG, Biron RT, Bear HD, Merchant RE.
    J Neurooncol; 1997 Mar; 32(1):29-38. PubMed ID: 9049860
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors.
    Badn W, Visse E, Darabi A, Smith KE, Salford LG, Siesjö P.
    J Immunol; 2007 Sep 15; 179(6):4231-8. PubMed ID: 17785863
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J, Wang C, Wang B, Yang J, Wang Y, Luo F, Xu J, Zhao C, Liu R, Chu Y.
    J Neuroinflammation; 2018 Oct 17; 15(1):290. PubMed ID: 30333036
    [Abstract] [Full Text] [Related]

  • 7. IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma.
    Natsume A, Tsujimura K, Mizuno M, Takahashi T, Yoshida J.
    J Neurooncol; 2000 Apr 17; 47(2):117-24. PubMed ID: 10982152
    [Abstract] [Full Text] [Related]

  • 8. Immunoregulatory role in gamma interferon production by a T cell growth factor-dependent experimental malignant glioma-specific cytotoxic T lymphocyte clone.
    Yamasaki T, Handa H, Yamashita J, Watanabe Y, Taguchi M, Kuwata S, Namba Y, Hanaoka M.
    J Neurosurg; 1985 Nov 17; 63(5):763-70. PubMed ID: 3932609
    [Abstract] [Full Text] [Related]

  • 9. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes.
    Baldwin NG, Rice CD, Tuttle TM, Bear HD, Hirsch JI, Merchant RE.
    J Neurooncol; 1997 Mar 17; 32(1):19-28. PubMed ID: 9049859
    [Abstract] [Full Text] [Related]

  • 10. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.
    Fecci PE, Sweeney AE, Grossi PM, Nair SK, Learn CA, Mitchell DA, Cui X, Cummings TJ, Bigner DD, Gilboa E, Sampson JH.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4294-305. PubMed ID: 16857805
    [Abstract] [Full Text] [Related]

  • 11. [Effects of interferons on syngeneic murine malignant glioma-specific killer T cell].
    Yamasaki T, Yamashita J, Handa H, Namda Y, Hanaoka M.
    No Shinkei Geka; 1983 Oct 15; 11(10):1059-67. PubMed ID: 6196674
    [Abstract] [Full Text] [Related]

  • 12. Cervical lymph nodes play the role of regional lymph nodes in brain tumour immunity in rats.
    Okamoto Y, Yamashita J, Hasegawa M, Fujisawa H, Yamashima T, Hashimoto T, Nonomura A, Matsumoto Y, Kida S.
    Neuropathol Appl Neurobiol; 1999 Apr 15; 25(2):113-22. PubMed ID: 10215999
    [Abstract] [Full Text] [Related]

  • 13. Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment.
    Pellegatta S, Poliani PL, Stucchi E, Corno D, Colombo CA, Orzan F, Ravanini M, Finocchiaro G.
    Neuro Oncol; 2010 Apr 15; 12(4):377-88. PubMed ID: 20308315
    [Abstract] [Full Text] [Related]

  • 14. Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model.
    Chirasani SR, Leukel P, Gottfried E, Hochrein J, Stadler K, Neumann B, Oefner PJ, Gronwald W, Bogdahn U, Hau P, Kreutz M, Grauer OM.
    Int J Cancer; 2013 Feb 15; 132(4):843-53. PubMed ID: 22752934
    [Abstract] [Full Text] [Related]

  • 15. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A, Oh S, Gharagozlou S, Vedi RN, Ericson K, Low WC, Chen W, Ohlfest JR.
    J Immunother; 2007 Feb 15; 30(8):789-97. PubMed ID: 18049330
    [Abstract] [Full Text] [Related]

  • 16. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
    Jiao H, Yang B, Guan F, Li J, Shan H, Song L, Hu X, Liang S, Du Y, Jiang C.
    Neurol Res; 2011 May 15; 33(4):405-14. PubMed ID: 21535940
    [Abstract] [Full Text] [Related]

  • 17. Antitumor and antimetastatic effects of interleukin 12.
    Fujiwara H, Hamaoka T.
    Cancer Chemother Pharmacol; 1996 May 15; 38 Suppl():S22-6. PubMed ID: 8765411
    [Abstract] [Full Text] [Related]

  • 18. Intracerebral interleukin 12 induces glioma rejection in the brain predominantly by CD8+ T cells and independently of interferon-gamma.
    Vetter M, Hofer MJ, Roth E, Pircher HP, Pagenstecher A.
    J Neuropathol Exp Neurol; 2009 May 15; 68(5):525-34. PubMed ID: 19525900
    [Abstract] [Full Text] [Related]

  • 19. Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer.
    Ehtesham M, Samoto K, Kabos P, Acosta FL, Gutierrez MA, Black KL, Yu JS.
    Cancer Gene Ther; 2002 Nov 15; 9(11):925-34. PubMed ID: 12386831
    [Abstract] [Full Text] [Related]

  • 20. Cytokine production by CD4+ and CD8+ T cells in mice following primary exposure to chemical allergens: evidence for functional differentiation of T lymphocytes in vivo.
    Moussavi A, Dearman RJ, Kimber I, Kemeny DM.
    Int Arch Allergy Immunol; 1998 Jun 15; 116(2):116-23. PubMed ID: 9652304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.